AU2015205179B2 — Pharmaceutical composition containing pyridylamino acetic acid compound
Assigned to Santen Pharmaceutical Co Ltd · Expires 2019-09-19 · 7y expired
What this patent protects
The purpose of the present invention is to provide a pharmaceutical composition that contains a specific compound and exhibits a superior preservation efficacy, the specific compound being stable within the pharmaceutical composition, and to provide methods for improving the stab…
USPTO Abstract
The purpose of the present invention is to provide a pharmaceutical composition that contains a specific compound and exhibits a superior preservation efficacy, the specific compound being stable within the pharmaceutical composition, and to provide methods for improving the stability of the specific compound within the pharmaceutical composition and the preservation efficacy of the pharmaceutical composition. The pharmaceutical composition according to the present invention contains (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-yl amino) isopropyl acetate or a salt thereof, and further contains edetic acid or a salt thereof.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.